Page last updated: 2024-10-26

felbamate and Absence Seizure Disorder

felbamate has been researched along with Absence Seizure Disorder in 1 studies

Felbamate: A PEGylated phenylcarbamate derivative that acts as an antagonist of NMDA RECEPTORS. It is used as an anticonvulsant, primarily for the treatment of SEIZURES in severe refractory EPILEPSY.
felbamate : The bis(carbamate ester) of 2-phenylpropane-1,3-diol. An anticonvulsant, it is used in the treatment of epilepsy.

Research Excerpts

ExcerptRelevanceReference
" PTZ test was influenced by meprobamate in a fairly low dosage (ED50 66 mg/kg), but for felbamate no clearly dose-related effect could be shown up to 150 mg/kg."1.30Felbamate and meprobamate: a comparison of their anticonvulsant properties. ( Bartels, I; Frey, HH, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frey, HH1
Bartels, I1

Other Studies

1 other study available for felbamate and Absence Seizure Disorder

ArticleYear
Felbamate and meprobamate: a comparison of their anticonvulsant properties.
    Epilepsy research, 1997, Volume: 27, Issue:3

    Topics: Animals; Anticonvulsants; Disease Models, Animal; Electroshock; Epilepsy, Absence; Felbamate; Female

1997